Breast Cancer

Automated Blood Test for Cancer Launched

Published in Cancer Weekly, September 1st, 1997

Biomira Inc., Edmonton, Alberta, Canada, confirmed that Chiron Diagnostics, a business unit of Chiron Corp. has announced the U.S. launch of ACS:180 BR, its automated blood test for the breast cancer associated antigen CA 27.29.

The test, incorporating the monoclonal antibody B27.29 licensed from Biomira, is now available in the United States to physicians to monitor their patients with metastatic breast cancer.

Biomira launched its Truquant BR RIA blood test kit for the detection of recurrent breast cancer in the U.S. in 1997, after a three-year clinical trial in patients previously treated for Stage II or Stage III breast cancer. The results,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry